Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
841,375
-
Share change
-
+73,685
-
Total reported value
-
$1,426,006
-
Price per share
-
$1.70
-
Number of holders
-
19
-
Value change
-
+$54,311
-
Number of buys
-
8
-
Number of sells
-
8
Institutional Holders of CytoDyn Inc. - COM (CYDY) as of Q2 2021
As of 30 Jun 2021,
CytoDyn Inc. - COM (CYDY) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
841,375 shares.
The largest 10 holders included
Firsthand Capital Management, Inc., FAIRFIELD, BUSH & CO., Capital Advantage, Inc., Willis Investment Counsel, L & S Advisors Inc, Diversified Trust Co, HOLLENCREST CAPITAL MANAGEMENT, Moloney Securities Asset Management, LLC, MAI Capital Management, and CAPTRUST FINANCIAL ADVISORS.
This page lists
19
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.